SUSCEPTIBILITY OF CLINICAL ISOLATES OF CANDIDA SPP TO TERCONAZOLE AND OTHER AZOLE ANTIFUNGAL AGENTS

被引：11
作者：
PFALLER, MA
GERARDEN, T
机构：
[1] VET ADM MED CTR,IOWA CITY,IA 52240
[2] UNIV IOWA,COLL MED,DEPT PATHOL,IOWA CITY,IA 52242
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1989年 / 12卷 / 06期
关键词：
D O I：
10.1016/0732-8893(89)90079-5
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：467 / 471
页数：5
相关论文
共 50 条
  • [31] Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species
    Nagayoshi, Yohsuke
    Miyazaki, Taiga
    Shimamura, Shintaro
    Nakayama, Hironobu
    Minematsu, Asuka
    Yamauchi, Shunsuke
    Takazono, Takahiro
    Nakamura, Shigeki
    Yanagihara, Katsunori
    Kohno, Shigeru
    Mukae, Hiroshi
    Izumikawa, Koichi
    PLOS ONE, 2017, 12 (07):
  • [32] In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
    Barchiesi, F
    Tortorano, AM
    Di Francesco, LF
    Cogliati, M
    Scalise, G
    Viviani, MA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) : 295 - 299
  • [33] Antifungal drug susceptibility profiles and molecular mechanisms of azole resistance in Candida blood stream isolates
    Yenisehirli, Guelguen
    Alici, Ayse
    Yenisehirli, Aydan
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2023, 45
  • [34] In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents
    Choukri, F.
    Benderdouche, M.
    Sednaoui, P.
    JOURNAL DE MYCOLOGIE MEDICALE, 2014, 24 (04): : 303 - 307
  • [35] Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex
    Melo, Analy S.
    Bizerra, Fernando C.
    Freymueller, Edna
    Arthington-Skaggs, Beth A.
    Colombo, Arnaldo L.
    MEDICAL MYCOLOGY, 2011, 49 (03) : 253 - 262
  • [36] Susceptibility of Candida spp. clinical isolates to antimycotics and disinfectants
    Staniszewska, Monika
    Rozbicka, Beata
    Rajnisz, Aleksandra
    Bocian, Ewa
    Wasinska, Ewa
    Jakimiak, Bozenna
    Roehm-Rodowald, Ewa
    Kurzatkowski, Wieslaw
    Tyski, Stefan
    CENTRAL EUROPEAN JOURNAL OF BIOLOGY, 2010, 5 (06): : 821 - 826
  • [37] In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole
    Cooper, CR
    McGinnis, MR
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (06) : 1626 - 1631
  • [38] IN VITRO SUSCEPTIBILITY OF Candida Spp. ISOLATED FROM CLINICAL SPECIMENS AGAINST SOME ANTIFUNGAL AGENTS
    Ozcelik, Berrin
    Balaban, Neriman
    Aksaray, Sebahat
    Cesur, Salih
    Kaynak, Fatma
    Cayirli, Altan
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 3 (01) : 1 - 6
  • [39] ANTIFUNGAL SUSCEPTIBILITY TESTING OF CANDIDA SPP BY RELATIVE GROWTH MEASUREMENT AT SINGLE CONCENTRATIONS OF ANTIFUNGAL AGENTS
    ODDS, FC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) : 1727 - 1737
  • [40] RESISTANCE OF CANDIDA-ALBICANS TO AZOLE ANTIFUNGAL AGENTS
    HITCHCOCK, CA
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1993, 21 (04) : 1039 - 1047
12345